MARY DICKERSON: Open Payments
NPI 1689005225 · FRANKFORD, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 22 payments from 13 companies in 2025. Trend: 2023 $114 · 2024 $364 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| MERZ NORTH AMERICA, INC. | 1 | $112 |
| Novo Nordisk Inc | 5 | $88 |
| Exact Sciences Corporation | 3 | $85 |
| Lilly USA, LLC | 2 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Amgen Inc. | 1 | $22 |
| PFIZER INC. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Xeomin, The Cologuard Plus Collection Kit, MOUNJARO, Kerendia, GARDASIL 9, OTEZLA, PREVNAR 20, SHINGRIX.
Industry payments across DE — which companies pay providers there.
